JOP2

The journey of a patient

with CVID

Meet Helen. She is a person with Common Variable Immune Deficiency (CVID), an heterogeneous group of diseases characterised by a significant failure to produce specific antibodies and susceptibility to bacterial infections.

The effects of CVID vary, most patients have recurrent infections, and some may have enlarged lymph nodes, autoimmune disorders as well as disease-related complications which affect their organs including their lungs, heart, bowel, spleen and liver.

Symptoms description

GENERAL

Fever
Fatigue

ENT

Sinusitis

Otitis

Tinnitus

Loss of hearing due to infections 

Dizziness in case of otitis
Allergy

NUTRITION

Eating disorders

Malabsorption

Denutrition

Obesity

GASTROENTEROLOGY

Gastro enteritis

Splenomegaly

Hepatomegaly

Loss of appetite,

Nausea, vomiting

Weight loss

Elevated liver enzymes Abdominal pain/discomfort Granulomas (liver, gut) Digestive ulcers

Chronic/recurrent diarrhoea Mucus and blood in stool 

(infection-related or inflammatory bowel disease related)

Infections (bacteria/viruses)

HAEMATOLOGY

Pancytopenia (anemia, thrombocytopenia, lymphopenia)

Lymphadenitis 

Haemolytic anemia 

Leukocytopenia

Very low IgG level 

Very low IgM level 

Very low IgA level 

Low IgG subclasses 

Lymphomas/Leukemia 

Hepato-splenomegaly

NEUROLOGY

Development
/growth delay
Meningitis Gait
/motor alterations

DERMATOLOGY

Skin infections (folliculitis, infections,
delayed scarring, warts)

Vasculitis

Purpura/petechiae 

Muscel skin layer painful 

Chronic/recurrent eczema Bruising

Silver hair, fragile hair 

Ombilical cord issues

RESPIRATORY

Wheeze
Difficulty breathing
Cough
Coughing up blood
Asthma
Repeated chest infections

RHEUMATOLOGY

Moving joint pains or inflammation

Arthritis

Osteopenia (in children/young) 

Osteoporosis

Recurrent tendinitis

INFECTIONS

Sepsis

Long lasting/severe/repeted varicella 

Recurrent/More severe/Atypical or opportunistic infections

Lymph nodes

Shingles

Repeated influenza

Recurrent fever/inflammation 

Need of intravenous antibiotics

REQUIRED PRACTITIONERS

General Practioners

Paediatricians

Internists

Microbiologists

Organ specialists: – Pulmonologist, – Digestive, – Dermatologist, – Hematologist, – Neurologist, – Rheumatologist, – Haematologists, – Immunologists, – Infectiologists,– Allergists – Dentists, – Ophtalmologists

Emergency ward 

Symptoms Challenges

HEALTH IMPACT

A wide range of very diverse symptoms:
– Varying from person to person
– Possibly changing throughout life
– Appearing in childhood as well as in adulthood

Various situations of onset:

• After repeated infections, pneumonias
• After autoimmune cytopenia
• After lymphadenopathy or splenomegaly enlargement
• After chronic diarrhoea
• After vaccine adverse reactions or infections
• After given birth
• After being in the sun
• After exercising

ACCESS

Symptoms are addressed rather than the underlying condition that is not diagnosed

ADDED RISKS

Risk of permanent organ damages (bronchiectasis/malignancy/death)

HEALTHCARE PROFESSIONALS AWARENESS & EDUCATION

Doctors don’t know about PIDs (ie when hospitalised…)

Lack of immunologist

PSYCHOLOGICAL & SOCIAL IMPACT

Living with a chronic invisible condition

Being regularly unwell

Being afraid of catching infections

Absences from work or from school.

Family burden (care-takers)

Stigma because of unusual symptoms

People being always ill, but not being believed they are ill

Financial challenges (ability to work)

Symptoms Needs

ACCESS

Early accurate diagnosis

Immunologists for children and adults

Expertise centres

QUALITY OF LIFE

Possibility for home schooling or available distance learning service from school

Possibility for home working

HEALTHCARE PROFESSIONALS AWARENESS & EDUCATION

Awareness on warning signs

Medical education of general practitioners and other healthcare professionals

RESEARCH

Research on these conditions

Publications

SUPPORT & ADVOCACY

Patient organisations

Diagnostic description

BIOLOGICAL
Decrease levels of
immunoglobulins
with abnormalities
count of B cells
Autoimmunity panels
Microbiological tests

CLINICAL
Family history
Prenatal study
Birth screening
Infection history

IMMUNISATION
Immunisation response

IMAGING
TECHNICS

GENETIC
TESTING

REQUIRED PRACTITIONERS

PID specialists

Immunologists

Organ specialists

Biologists

Psychologists

Social workers

Diagnostic Challenges

ACCESS

Patient odyssey before accurate diagnosis

Symptoms can appear before the age of 3, but no definitive diagnosis possible before age of 4

Misdiagnosis

Often not diagnosed until adulthood

Genetic counselling

Genetic testing

PSYCHOLOGICAL AND SOCIAL IMPACT

Difficulty for the patient/parents to accept the chonicity of the disease and of the treatment

HEALTH IMPACT

Severe, unusual, recurrent bacterial infections

Late diagnosis can lead to permanent organ damages Need of ENT (Ear, Nose, Throat) surgery(ies)

ACCESS TO EARLY, ACCURATE DIAGNOSIS

Possible associated conditions
Auto inflammation
Auto immunity
Allergy
Malignancy

Be hospitalised for another reason than the PID in the emmergency ward where doctors don’t know about PIDs and may not listen to the patient /parent

HEALTHCARE PROFESSIONALS AWARENESS & EDUCATION

Impact on both patient and carerMany specialists, no diagnosis

Not taken seriously by the doctors even adressed to a psychiatrist

Lack of medical knowledge on PIDs

Difficult to find doctors who know about PIDs

Lack of immunologists

Lack of Adult immunologists experts in PIDs

PIDs, and especially CVIDs, are ignored by most curriculas in many countries

Genetic counselling

Diagnostic Needs

ACCESS

Timely and accurate diagnosis

A network of expertise centres

MEDICAL PRACTICE

Reevaluation of diagnosis in time given the progress in the field (including the possibility of genetic testing)

When an indication for psychiatric drugs, need of psychiatry consultation

SUPPORT & ADVOCACY

Patient advocacy organisations

Stakeholders’ cooperation

DIGITAL HEALTH

Registries

Data sharing and interoperability

COMMUNICATION & COORDINATION

International Cooperation

HEALTHCARE PROFESSIONALS AWARENESS & EDUCATION

Need of Immunologists for children and adults (immunology not always considered as a subspeciality)

A range of medical specialists knowing CVIDs, including biologist, geneticist, infectiologist, psychologist, …

Immunology: More education for medical students, GPs, specialists at pre and postgraduation 

Treatment description

IMMUNOGLOBIN
REPLACEMENT
THERAPY REGULAR
AND LIFELONG

VACCINES

(specific for pid)

ANTIBIOTICS

(prophylaxis
or on-demand)

SPECIFIC MEDICINES

addressing specific
symptoms

REQUIRED PRACTITIONERS

PID specialists

Organ specialists knowingPIDs

Specialised nurses

Other Healthcare
professionals
(physiotherapist,
nutritionist,
dentists…)

Psychologists /
Psychiatrists

Social workers

Treatment Challenges

ACCESS

Supply tensions on immunoglobulins (Subcutaneous (SC) and Intravenous (IV) )

Access to best tolerated immunoglobulin therapy (SC and IV)

Supply tensions/shortages on antibiotics

Access to efficient and innovative therapies (anti-infectious, targeted therapies, …)

Access to off label immune suppressive drugs

Access to home therapy

CHRONICITY
OF TREATMENT

Treatment not well tolerated

Distance to travel to reach out to hospital for regular treatment

Distance to travel to get the medicine from hospital for home therapy

ADDED RISK

Microbial multi resistance

QUALITY OF LIFE

Fatigue

Time taken on family, work and social life for reccurent treatment

PATIENT EDUCATION & EMPOWERMENT

Patient compliance to their chronic treatment

Treatment Needs

ACCESS

Continuous supply of needed medicines

Cost coverage of needed medicines

Patient’s and physician’s (not hospital’s) choice of treatment regarding clinics and quality of life

HEALTHCARE PROFESSIONALS AWARENESS & EDUCATION\

Adapted medical devices (especially in children)

To take pain into account when administrating the treatment

MEDICAL PRACTICE

Personalised treatment

Multidisciplinary teamsMultidisciplinary teams

To adress side effects of treatment

Protocols to adjust therapy dosing or to withdraw anti-inflammatory therapy

Protocols on oncologic treatment in PID

Emergency protocols for PID patients

QUALITY OF LIFE

Facilitating home therapy after patient’s choice (availability, trained professionals, patients’ training, …)

PATIENT
ENGAGEMENT

To understand their disease, cope with it, be compliant with treatment

RESEARCH

On new ways to fight off multi drug resistant bacterias

On vaccines

Follow up & Ageing description

FOLLOW-UP OF
SPECIFIC ORGANS

(ie lung, liver…)

ADDED CO-
MORBIDITIES
LINKED TO AGE

RE-EVALUATE
TREATMENT
REGULARLY

TRANSITIONNING

REGULAR LIFELONG
VISITS WITH A PID
SPECIALIST

(vary from every 3 months
to every 2 years or more)

REQUIRED PRACTITIONERS

PID specialists

Organ specialists knowing PIDs

Specialised nurses

Emergency ward

Other Healthcare 
professionals 
(physiotherapists, nutritionists, …)

Gerontologists 

Psychologists 

Social Workers

Follow up & Ageing Challenges

ACCESS

Access to treatment

Distance to travel to reach out to specialists

MEDICAL
FOLLOW UP

Onset of new symptoms and biomarkers

Lymphomas and other malignancies

Processes and organisation for transitioning from paediatric to adult ward

Management of co-morbidities

Immunologists for adults or internists knowing PIDs/CVIDs

Identifying other specialists knowing PIDs

Follow up & Ageing Needs

MEDICAL PRACTICE

A range of medical specialists knowing CVIDs

Transitioning programmes for adolescent and aging persons

Follow-up protocols

COMMUNICATION AND COORDINATION

Communication between local hospitals/GPs and reference centres to ensure an optimal environment for the management of the condition and emergencies

Multidisciplinary team taking a holistic approach

DIGITAL HEALTH

Telemedicine